Genotoxicity of sodium metabisulfite in mouse tissues evaluated by the comet assay and the micronucleus test

Ivana M C M M Carvalho1, Ana A C Melo Cavalcante, Alisson F Dantas

  • 1Programa de Pós-Graduação em Genética e Toxicologia Aplicada-Universidade Luterana do Brasil, Canoas, RS, Brazil.

Mutation Research
|December 28, 2010
PubMed

Insights

Sodium metabisulfite (SMB), used in food and pharmaceuticals, showed genotoxic effects in mice at high doses. Further research is needed to understand the genotoxic risk of SMB in different tissues.

Area of Science:

  • Toxicology
  • Genetics

Background:

  • Sodium metabisulfite (SMB) is a common additive in food and pharmaceuticals.
  • It possesses antimicrobial and antioxidant properties.
  • Concerns exist regarding its potential genotoxic effects.

Purpose of the Study:

  • To evaluate the genotoxic effects of sodium metabisulfite (SMB) in various mouse tissues.
  • To assess the risk associated with high oral doses of SMB.

Main Methods:

  • Genotoxicity was assessed using the comet assay in liver and blood cells.
  • The micronucleus test was performed on blood and bone marrow cells.
  • Doses of 1 and 2g/kg of SMB were administered orally.

Main Results:

  • Significant increases in DNA damage index and frequency were observed in SMB-treated mice.
  • Elevated micronucleus frequencies were noted in peripheral blood and bone marrow at the highest SMB dose (2g/kg).
  • A reduction in the polychromatic to normochromatic erythrocyte ratio indicated potential bone marrow toxicity.

Conclusions:

  • High oral doses of sodium metabisulfite (SMB) may pose a genotoxic risk.
  • The study highlights the need for careful consideration of SMB dosage in food and pharmaceutical applications.
  • No sex-based differences in genotoxic effects were observed.